Package 0093-7473-06

Brand: capecitabine

Generic: capecitabine
NDC Package

Package Facts

Identity

Package NDC 0093-7473-06
Digits Only 0093747306
Product NDC 0093-7473
Description

60 TABLET, FILM COATED in 1 BOTTLE (0093-7473-06)

Marketing

Marketing Status
Marketed Since 2014-03-07
Brand capecitabine
Generic capecitabine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "94cd2146-70ff-43e3-a896-b9e55d75540f", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["6804DJ8Z9U"], "rxcui": ["200327", "200328"], "spl_set_id": ["5753679a-506c-4ac4-b8b2-b27c664d1d40"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (0093-7473-06)", "package_ndc": "0093-7473-06", "marketing_start_date": "20140307"}], "brand_name": "Capecitabine", "product_id": "0093-7473_94cd2146-70ff-43e3-a896-b9e55d75540f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "0093-7473", "generic_name": "Capecitabine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Capecitabine", "active_ingredients": [{"name": "CAPECITABINE", "strength": "150 mg/1"}], "application_number": "ANDA091649", "marketing_category": "ANDA", "marketing_start_date": "20140307", "listing_expiration_date": "20271231"}